Renxue Xiong
Hangzhou, 310009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
MitoQ upregulates CYP19A1 to protect dermal papilla cells from DHT-induced mitochondrial dysfunction and apoptosis in androgenetic alopecia.
Journal: Biochemical pharmacology
Published: November 07, 2025
MitoQ for vitiligo by mitigating PARP1 translocation aberrations: Network pharmacology and experimental validation.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: January 02, 2025
MitoQ alleviates H2O2-induced mitochondrial dysfunction in keratinocytes through the Nrf2/PINK1 pathway.
Journal: Biochemical pharmacology
Published: July 14, 2024
MitoQ enhances CYP19A1 expression to stimulate WNT/β-catenin signaling pathway for promoting hair growth in androgenetic alopecia.
Journal: European journal of pharmacology
Published: July 08, 2024
NAcM-OPT protects keratinocytes from H2O2-induced cell damage by promoting autophagy.
Journal: Annals of the New York Academy of Sciences
Published: June 26, 2024
Application of multi-omics techniques to androgenetic alopecia: Current status and perspectives.
Journal: Computational and structural biotechnology journal
Published: March 10, 2024
The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: March 01, 2024
DCUN1D1, a new molecule involved in depigmentation via upregulating CXCL10.
Journal: Experimental dermatology
Published: September 30, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026